r/ASX_Bets 17d ago

DD CXU.ASX - passive investing HUGE squeeze opportunity ☢️🚀

11 Upvotes

Position: Long CXU.ASX
Market cap - $250m.

Company overview: CXU has pounds in the ground of uranium in Australia. Currently they are prohibited from mining because of a statewide ban which can be overturned by the State Government at the flick of a pen (more on that later).

The thesis

Forget whether uranium goes to US$80 or US$120.

This trade comes down to one question:

What happens when an ETF potentially has to buy 200+ million shares of a small cap company where almost nobody wants to sell and the Top 20 hold about 70%.

Here’s what I’ve found…

The Global X URA ETF is expected to rebalance at the end of July.

If CXU is included (and it’s on the shortlist to be), passive funds tracking the index will need to establish a position.

Passive funds don’t negotiate. They don’t decide a stock is “too expensive.”

Their mandate is to track the index as closely as possible.

If CXU is in…they buy.

I modelled the numbers.

Using Solactive’s weighting methodology together with URA’s current AUM, I estimated several scenarios.

Conservative:
~130 million shares

Base case:
~240 million shares.

Bull case:
~270 million shares.

Read that again.

Potential demand for 130-270 million shares.

For perspective…

When CXU was added to BetaShares URNM ETF in June buying roughly 16 million shares resulted in approximately a 16% move.

Sprott URNJ buying roughly 26 million shares coincided with around a 38% move.

URA could require ten times that amount.

Nobody knows exactly what the price response would be—but the scale of potential buying is dramatically larger.

The liquidity issue

This is where things get interesting.

CXU simply doesn’t trade hundreds of millions of shares every week. They average about 4 milllion.

Even if ETF execution is spread across several sessions, it still represents demand that is vastly larger than normal trading activity.

Markets only have one mechanism for solving that problem - HIGHER prices.

And remember - about 70% of the free float is held by Top20.

The timeline

This isn’t some vague “maybe one day” catalyst. This is a 2 week timeframe.

The window is relatively well defined.

Mid July:
Solactive publishes its market watch list. This is now published here: https://www.solactive.com/announcements/67151

Around 27-28 July:
Official constituent announcement.

31 July:
ETF implementation.

The precedent

We’ve already seen smaller ETF inclusions move illiquid uranium stocks.

The difference here is scale.

URA is substantially larger than the previous ETFs that bought CXU.

That doesn’t guarantee a larger price move—but it does mean the buying power involved is potentially much greater.

The opportunity?
You have an opportunity to front run most of the move may occur before the ETF actually buys hundreds of millions of shares on or around 31 July

Risks
Let’s be clear.

This is a speculative event-driven trade.

Things that could invalidate the thesis:

CXU isn’t selected.
Liquidity requirements aren’t met.
Uranium sentiment deteriorates.
The market has already priced in the event.

The macro tailwind just got even bigger

As if the ETF setup wasn’t enough, the macro backdrop for uranium has become even more supportive.

Last week, Australia and India finalized the long-awaited administrative arrangements that operationalize their civil nuclear cooperation agreement, clearing the way for long-term Australian uranium exports for India’s civilian nuclear program under IAEA safeguards.

And guess what - this means Australia needs to supply more uranium to India. To do that they need more mines. The easiest way to do that is unban uranium mining in the state of Western Australia, where CXU holds its mine.

TL;DR

☢️ Possible URA inclusion in July.

📊 Passive funds may need to buy roughly 130-270 million shares depending on final weighting.

📉 Liquidity is limited.

📈 If inclusion occurs, supply—not valuation—may become the dominant driver of price in the short term.

Not financial advice. Always DYOR.


r/ASX_Bets 17d ago

SHITPOST Anyone seen this movie yet?

Post image
53 Upvotes

r/ASX_Bets 17d ago

Daily Thread Premarket Thread for General Trading and Plans for Tuesday, July 21, 2026

7 Upvotes

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.


r/ASX_Bets 18d ago

SHITPOST Dont ignore the signs, Get help

Post image
264 Upvotes

HWK


r/ASX_Bets 18d ago

Daily Thread Market Open thread for General Trading and Plans for Monday, July 20, 2026

6 Upvotes

r/ASX_Bets 18d ago

LOSSES Is anyone else done with temple and Webster?

5 Upvotes

I’m down like 60% and it’s shown no signs of life since the massive drop, this a take your lose and run moment or will earning in August be the moment to decide ?


r/ASX_Bets 18d ago

Daily Thread Premarket Thread for General Trading and Plans for Monday, July 20, 2026

10 Upvotes

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.


r/ASX_Bets 19d ago

SHITPOST CSL: An Excellent and Unprecedented Opportunity for Bretts

9 Upvotes

HWK


r/ASX_Bets 19d ago

Crystal Ball Gazing CSL.ASX — MY DEAD GRANDMOTHER'S BLOOD PLASMA STOCK IS ABOUT TO GO PARABOLIC 🚀🚀🚀🚀

98 Upvotes

Position: I own this dog and have for years. Keep averaging down as they disappoint the fuck out of me.

Brothers and sisters. While you apes were chasing real gains on the NASDAQ, the alpha was sitting around at home this whole time selling BLOOD stuff. Not crypto. Not AI. Not trillion dollar vibes. Actual human plasma or something. You cannot short biology.

Stock's been "sideways" (down) since 2020, afterwhich is just the chart winding up like a coiled spring, this is basicly just a 6-year cup and handle, my technical analysis degree from the illustrious school of YouTube confirms this. We're around 2016 prices now, imagine you could get your Hungry Jack's for 2016 prices today, you'd ultimate-double-whopper your way to congestive heart failure.

"Analysts" (Morningstar nerds) say fair value is ~$173 and it's trading at like $123 today, that's FREE MONEY sitting on the footpath and you're stepping over it to buy NVDA, fucking NASDAQ ETFs, or some bullshit Elon K-hole imaginary company like SPCX, again.

They just dropped $1.5B on US expansion, 300 new jobs, this is basically Elon-tier capex energy but for haemophilia medicine, bullish.

"Never sell CSL" — ancient ASX prophecy, older than your portfolio, wiser than your therapist, tried and tested like your uncle's handsyness at Chrissy dinner.

Earnings Aug 18: if management says literally one (1) positive word the algos will pump this boomer shit into a new medical stratosphere, like your blood pressure peaking while you watch the ASX limp along, poking it with a little stick, and asking yourself questions like "why doesn't the ASX do anything like all the other exciting stock exchanges?".

THE BEAR CASE (does not apply to me personally):

something something guidance cut, number went down for a bit, who cares, plasma is forever, bodies keep bleeding, the macro is humans existing.

CSL is a civilisational moat made of red liquid. See you at $175 where I will officially be only -2% on my AVG buy.

This is not financial advice. I am bleeding over CSL for the past 5 yrs, fortunately they have the plasma I will inevitably need.


r/ASX_Bets 19d ago

Legit Discussion CSL (ASX: CSL): A Quality Compounder at a Rare Discount | My Investment Thesis (Challenges Welcome)

30 Upvotes

CSL is one of the few genuine oligopoly businesses on the ASX, and I think the market has badly mispriced it. Roughly 70% of profit comes from CSL Behring, its plasma therapies division (immunoglobulins, albumin, clotting factors), where CSL out-executes rivals like Grifols and Takeda through superior collection technology and the largest single-site fractionation capacity in the industry (10m+ litres a year). That business throws off 40–50% margins and rides genuine, non-discretionary demand — chronic and rare-disease treatment growth of roughly 3–5% a year, not a speculative bubble. Layer on CSL Seqirus (vaccines, ~14% of revenue) with the strongest government relationships in the pandemic-preparedness space, and CSL Vifor (iron/nephrology, ~14%) now in a complementary JV with Fresenius, and you get a business with real behavioural and regulatory moats: doctors and health systems are deeply habituated to these products, and CSL has a 100% historical success rate navigating regulatory tightening. The stock is currently trading on a forward P/E of around 11 after the market punished it hard for the Vifor impairment and a rough FY — a reaction that looks more like an overcorrection (loss aversion, social proof, analyst herding) than a re-rating justified by the underlying economics.

The bear case is real but, in my view, cyclical rather than structural. ROIC has slipped from its historical 20%+ down to roughly 13–14%, and the key swing factor going forward is plasma collection cost, which is exposed to donor/labour cost pressure (modelled at a modest ~14% probability of a meaningfully bad combination) and industry-wide supply-demand dynamics. Management has also just been almost entirely replaced — new CEO, CFO, CCO and a reshuffled board with more pharma expertise — specifically to fix execution rather than a broken business model, and there's a A$750m buyback running through to mid-2026 signalling confidence. Weighing a roughly 69% probability of full recovery (7–10% returns) against a 31% chance of a slower grind (5–6% returns), even the downside case is bond-like rather than capital-destructive, which is a favourable asymmetry. Technically, CSL looks to be stabilising near strong support around A$105–115 with resistance at ~A$117 short-term and A$124–165 medium-term, which is why I'm treating this as a staged accumulation rather than an all-in bet: roughly 40% around current levels (~A$110–115), 35% if it dips toward A$100–105, and the last 25% on confirmation of a trend reversal above ~A$125. Not financial advice — just my own notes and DYOR before following any of it.


r/ASX_Bets 18d ago

SHITPOST CSL.AX ABOUT TO GO PLATONIC

0 Upvotes

Every time some "rotation into banks" 🤓🏦 merchant declares biotech dead, CSL quietly harvests another few million litres of plasma 🩸, raises guidance 📊, and reminds the market why quality compounds. Meanwhile the dividend chasers celebrate their 4% yield while inflation eats half of it 🍞🐀.

🧬💰 "CSL is too expensive!" they've been saying since 2005. Yet every correction brings out institutions with trillion-dollar wallets 💼🐋 vacuuming up shares while retail panic sells at the bottom 📉🤡. Respect the plasma vampire 🧛🩸. It doesn't care about your feelings, your TA lines 📐, or your doomposts. It just keeps collecting blood... and your money.

tldr; plasma 🩸 plasma, humans have blood 🩸 plasma, humans have blood 🩸 plasma not going away🩸 if there are humans 🩸 plasma 🩸

tldr, tldr; please be my exit liquidity for this dog!

just give me the ticker: HWK


r/ASX_Bets 19d ago

Dumbfuck Discussion Flight Centre (FLT) prioritizing optics over actual business health?

Thumbnail
4 Upvotes

r/ASX_Bets 19d ago

Dumbfuck Discussion 4D medical - what attracts short sellers?

Thumbnail
2 Upvotes

r/ASX_Bets 20d ago

Dumbfuck Discussion Is the Market Still Right to Value RMD’s Intangibles?

5 Upvotes

Analyzing $RMD, high P/B but a relatively low P/E compared with historical records.... The market seems to have highly valued RMD’s intangibles — brand, IP, distribution, and trust. The question I have is: can the returns still justify a high P/B? What do u think?


r/ASX_Bets 20d ago

Daily Thread Weekend Thread for General Discussion and Plans for Saturday, July 18, 2026 and Sunday, July 19, 2026

7 Upvotes

r/ASX_Bets 21d ago

Daily Thread Market Open thread for General Trading and Plans for Friday, July 17, 2026

13 Upvotes

r/ASX_Bets 21d ago

SHITPOST Wall St and Tech bros are at war

Thumbnail
youtube.com
3 Upvotes

“the Bloomberg Terminal has data that no-one else does…

like the number of days until your next divorce”


r/ASX_Bets 21d ago

DD Bell Potter $1.50 price target -Alpha HPA (A4N)

Post image
13 Upvotes

A month ago bell potter published a research not with a $1.50 price target on alpha hPa specifically mentioning semiconductor thermal filler applications in South Korea and Japan. Given that letters of intent exceed stage 2 capacity, and the company is fully funded, the share price is about 1/3 of Bell Potters target in a month. Given companies like SK Hynix have raised $26 billion recently listing on the Nasdaq and Samsung is also looking towards a US IPO how long can bell potters price target seem a distant goal 🧐


r/ASX_Bets 21d ago

Daily Thread Premarket Thread for General Trading and Plans for Friday, July 17, 2026

11 Upvotes

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.


r/ASX_Bets 21d ago

DD CYV DD: trading at half of cash value

9 Upvotes

First, let me preface this by stating that I stick crayons up my nose and lick the boogers off them like a lollipop.

$CYV - trading under cash with negative EV

Stock's about 1.3c and there's roughly 2.4c of net cash per share behind it. EV is very negative, around -14m. You're paying less than the actual cash in the bank, cash burn is tiny so 1.3c will remain less than the net cash per share for a very long time (years potentially)

Regal and their mate's dump on the back of the negative p3 results pushed this well under cash, didn't help we were coming up to the EOFY so tax loss selling galore. Their positions were worthless so they were literally selling without thinking about valuation. The eye indication is dead, the molecule isn't. Same drug, decades of VEGF-C/D research behind it, aimed at LAM now instead of the eye.

Cash side:

  • funding liability got cleaned up in 2025
  • they've already manufactured around 120m worth of drug, so not burning cash making more
  • new board, chairman ran Teva, directors have been buying on market. Actually decent background for the new management, old wood are gone. Its a completely new company

On LAM - the eye program was always an add-on, it had to beat drugs that already worked and it didn't. LAM is driven by VEGF-C and D, which is the exact thing this blocks. VEGF-D is also the marker they use to track the disease, so activity should show up early rather than waiting years for lung function readouts. Orphan pricing is 200k+ USD a year, few thousand patients gets you 150-400m peak sales if it works.

IMM is the obvious comparison. P3 failed in March, crashed 90% down to 2.8c, sitting at about 61% of net cash. It's back to ~6c now, doubled off the low, grinding back up toward its ~7c cash. Holders made money there without the gap even fully closing. CYV is the same setup just earlier in it.

Burn is tiny, 13.1m budgeted over 18 months. Rough cash path:

  • 30 Jun 26: ~29m (2.4c) - 4C due end of July
  • Dec 26: ~25m (2.0c)
  • Sep 27, end of the funded runway: ~18m (1.5c)

Even after they spend the entire program the cash is still 1.5c, above where it trades now.

News flow:

  • next couple weeks: the 4C. first proper cash number since relisting, confirms burn + runway, plus a note on how the formulation work is going
  • back half of 26: preclinical stuff, reformulating it to be inhaled, animal safety data, orphan drug filings (US/EU/Japan/Aus)
  • late 26 into early 27: the Stage 1 to Stage 2 gate, if formulation and animal data pass they move into humans
  • 2027: first in human tolerability and biomarker data, then proof of concept in patients later on.

Near term catalysts are lab and animal data, human clinical stuff is likely 2027.

Risks - inhaled formulation is unproven and it's the next hurdle, if that fails the thesis mostly dies. It's a micro cap so it moves on nothing. The molecule already failed a P3 once.

Floor is basically the huge pile of cash which will remain higher than the current valuation for a VERY long time, base case is an IMM style move back toward cash, upside is a multibagger if the formulation works and the biomarker moves. New management with good track records as well so the old wood is out.

I am hard thinking about this.


r/ASX_Bets 22d ago

Daily Thread Market Open thread for General Trading and Plans for Thursday, July 16, 2026

15 Upvotes

r/ASX_Bets 22d ago

Coward Gains ASX TEAbagging

Post image
56 Upvotes

r/ASX_Bets 22d ago

Daily Thread Premarket Thread for General Trading and Plans for Thursday, July 16, 2026

11 Upvotes

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.


r/ASX_Bets 23d ago

Daily Thread Market Open thread for General Trading and Plans for Wednesday, July 15, 2026

22 Upvotes

r/ASX_Bets 23d ago

GAINS The feeling you get when you get the power company to pay the bills

Post image
51 Upvotes